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Background: Adipose-derived stromal cells (ADSCs) are a good alternative to multipotent stem cells for regenerative
medicine. Low tidal volume (LVT) has proved to be an effective ventilation strategy. However, it is not known if ADSCs
and LVT can protect against ventilator-induced lung injury (VILI). This study was aimed to determine the potential of
ADSCs and LVT to repair following VILI and to elucidate the mechanisms responsible for this section.
Methods: A total of 72 rats were randomly assigned into group I (sham group, n = 18), group II (1 h of high tidal
volume-ventilated (HVT) 40 mL/kg to peak airway pressures of approximately 35 cm H2O and 100% oxygen, n = 18),
group III (1 h of HVT followed by 6 h LVT 6 mL/kg to peak airway pressures of approximately 6 cm H2O and 100%
oxygen, n = 18) and group IV (1 h of HVT followed by intravenous injection of 5 × 106 ADSCs, n = 18). All animals were
sacrificed 7 after the experiments lasted for 7 hours. Bronchoalveolar lavage fluid (BALF) was collected and lungs were
harvested for analysis.
Results: High tidal volume-ventilated (HVT) rats exhibited typical VILI features compared with sham rats. Lung edema,
histological lung injury index, concentrations of total protein, total cell counts, number of neutrophils in
bronchoalveolar lavage fluid (BALF), tumor necrosis factor-α, interleukin (IL)-1β, IL-6, IL-10 and transforming growth
factor-β1 in BALF were significantly increased in HVT rats. Additionally, gene and protein levels of Na+ channel subunits,
Na-K-ATPase pump activity and alveolar fluid clearance were significantly decreased in HVT rats. All these indices of VILI
were significantly improved in rats treated with ADSCs. However, compared with ADSCs treatment, LVT strategy had
little therapeutic effect in the present study.
Conclusion: These results may provide valuable insights into the effects of ADSCs in acute lung injury.
Keywords: Cell therapy, Ventilator-induced lung injury, Alveolar fluid clearance, Na+ channel, Na,K-adenosine
triphosphataseIntroduction
Acute lung injury (ALI) and its more devastating form,
acute respiratory distress syndrome (ARDS), are devas-
tating clinical syndrome of the lung [1] and important
causes of morbidity and mortality in critically ill patients
[2]. Pathologically, ALI/ARDS are characterized by dam-
age to the “pulmonary alveoli-capillary” barrier leading
to the accumulation of protein-rich edema fluid in the
alveolar space.* Correspondence: LingPei49@vip.sina.com
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University, 155 Nanjing Bei Street, Shenyang 110001, China
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reproduction in any medium, provided the orActive Na+ transport across the alveolar epithelium is a
major determinant of alveolar fluid clearance (AFC) from
the alveolar space into the interstitium and the pulmon-
ary circulation. Na+ enters the cell via the Na+ channel
(ENaC) located at the apical surface [3] and is subse-
quently pumped out of the cell by the Na,K-adenosine
triphosphatase (Na,K-ATPase) on the basolateral side [4].
ENaC is a heterotrimer of three transmembrane subunits
(α, β, and γ), which are able to reconstitute a functional
channel [5]. α-ENaC gene knock-out mice which was un-
able to clear alveolar edema fluid died within 40 hours after
birth [6]. β-ENaC and γ-ENaC gene were proved to influ-
ence the alveolar edema fluid absorption that was essentialtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pivotal role in AFC. Most patients with ALI/ARDS
have impaired AFC [9] which is associated with poor
prognosis [10]. Furthermore, up-regulation of ENaC and
Na,K-ATPase is known to increase active Na+ trans-
port, leading to a decrease in the severity of ALI [11]
and improved survival in animals and humans with
ALI/ARDS [12].
Patients with ALI/ARDS frequently require mechanical
ventilation (MV) to decrease work of breathing and to
maintain adequate gas exchange. However, high tidal
volume (HVT) MV may result in deleterious physiologic
and morphologic alterations [13]. MV can directly induce
ALI (ventilator-induced lung injury, VILI) by damaging the
alveolocapillary barrier [1,14], inducing proinflammatory
cytokines [15]. Furthermore, MV can directly impair AFC
accompanied by a significant decrease in activity of Na,
K-ATPase and active Na+ transport [16].
A new therapeutic approach involves developing strat-
egies that enhance lung repair following VILI. Accumulat-
ing evidence from studies on animal models and human
pulmonary tissue has shown that mesenchymal stem cell
(MSC) therapy potential to improve pulmonary function in
various pulmonary diseases, including ALI [17]. The pro-
posed mechanisms include inhibition of inflammatory reac-
tions, immunomodulation, and repair of damaged epithelial
cells. Bone marrow (BM)-derived stem cells have been the
primary source of stem cells for tissue engineering applica-
tions [18]; however, isolation of BM-MSCs requires bone
marrow aspiration, which is a moderate-risk procedure
[19]. The greatest limitation of isolated MSCs from aspi-
rated bone marrow is the low numbers of cells that can be
obtained from the limited volume of marrow [20]. Recent
studies have shown that subcutaneous adipose tissue has
distinct advantages over other stem cell sources because of
the ease of obtaining cells with minimal invasiveness, and
the ability of these cells to be readily cultured to a sufficient
number for autologous transplantation without the ethical
issue of allografting. Moreover, it has been demonstrated
that, ADSCs secrete significantly more bioactive fac-
tors than BM-derived stem cells, which may account
for their superior anti-inflammatory and regeneration-
enhancing properties [21].
The use of low tidal volumes during ventilation in
patients with acute lung injury may reduce the release
of inflammatory mediators [22]. Studies in animal models
also demonstrated that low tidal volume ventilation
protects both the alveolar epithelium and the endothe-
lium in acid aspiration-induced ALI [14,23], suggesting
a therapeutic benefit of this ventilation strategy in the
management of ALI/ARDS. To date this low ventila-
tion which is lung protective remains the only inter-
vention with a confirmed benefit on clinical outcome
and clearly demonstrates how studies on ALI/ARDS inorgan and animal models have translated into a suc-
cessful therapeutic strategy.
Currently, little is known regarding the effect of ADSCs
and LVT in experimental models of ALI and pulmonary
edema. Therefore, the aim of this study was to investigate
and compare the effects of ADSCs and LVT on ENaC and
Na,K-ATPase in vivo. We hypothesized that the administra-
tion of ADSCs and LVT might increase the activities of
ENaC and Na,K-ATPase in an acute animal model of VILI,
and might thus improve AFC.
Materials and methods
Pathogen-free adult male Sprague–Dawley rats were
obtained from the Laboratory Animal Center of China
Medical University. All experimental animal procedures
were performed in accordance with the Guide for the
Care and Use of Laboratory Animals (National Institutes of
Health (NIH) Guide publication no. 85–23, revised 1985,
http://grants.nih.gov/grants/olaw/Guide-for-the-Care-and-
Use-of-Laboratory-Animals.pdf and approved by the Ethics
Review Committee for Animal Experimentation of the
China Medical University.
Isolation, culture and characterization of ADSCs
ADSCs were isolated from the inguinal fat pad by enzyme
digestion and cultured as described previously with minor
modifications [24]. Briefly, the adipose tissues were minced
into small <1 mm3 fragments and incubated with 0.1% col-
lagenase type I (Sigma-Aldrich, USA) in water bath under
continuous shaking (37°C, 90 min) to digest the tissue. Col-
lagenase was then neutralized by adding an equivalent
DMEM/F12 (Gibco, USA) containing 10% fetal bovine
serum (FBS; Gibco) to the tissue sample. The digested
tissues were separated from the floating adipocytes by two
centrifugations at 600 g for 5 min at room temperature.
The mature adipose cells on the upper layer were removed
and the pellet, as the stromal vascular fraction, was
resuspended and filtered through a 40-μm filter. The
fraction was then centrifuged for 5 min (50 g) to remove
supernatant containing the cell debris. The cell pellets
were plated in 25-cm2 culture flasks (Corning, USA) filled
with 5 ml DMEM/F12 containing 15% FBS and 100 μg/ml
penicillin/streptomycin. Cell cultures were maintained in
a humidified tissue culture incubator (37°C, 5% CO2) and
the medium was subsequently changed every 3 days for
further cultivation. When ADSCs reached 90% conflu-
ence, the cells were passaged by 0.25% trypsin and 0.05%
EDTA (Gibco) for analysis or transplantation. This study
used ADSCs at their third passage.
To induce osteogenic differentiation, cells were cultured
for 3 weeks in osteogenic medium (DMEM supplemented
with 10% FBS, 10 mM β-glycerophosphate, 0.1 mM dexa-
methasone, and 50 mM ascorbic acid), as described previ-
ously [25]. Early mineralization was detected using Alizarin
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adipogenic differentiation medium (DMEM containing 10%
FBS, 0.5 mM isobutylmethylxanthine, 200 μM indometh-
acin, 10 μM bovine insulin, and 1 μM dexamethasone), and
Oil Red-O staining was performed after 21 days [26].
For phenotypic characterization, approximately 1 × 105
cells were incubated for 30 min with monoclonal anti-
bodies to CD29, CD105, CD90, CD45 and CD14 labeled
with fluorescein isothiocyanate or phycoerythrin. Cells
were analyzed using fluorescence-activated cell sorter
(FACSCalibur, BD Biosciences, USA) and Cell Quest
software.
Induction of VILI and administration of ADSCs
Two weeks after surgery, Sprague–Dawley (body weights
260 ± 16 g) rats were anesthetized by intraperitoneal in-
jection of pentobarbital 75 ml/kg (Sigma-Aldrich, USA).
The rectal temperature of the rats was maintained within
the range of 36.5–37.5°C throughout the procedure. Rats
were placed supine and ventilated through a tracheotomy
tube (16-gauge, Becton Dickinson, USA) with a volume-
controlled ventilator (Model 683; Harvard Apparatus,
South Natick, MA) at the following settings. A total
of 72 animals were randomly assigned to four groups
(n = 18 each). Group I: sham group; animals received
no VILI or treatment and were kept under spontaneous
breathing for the entire duration of the experiment. Group
II: HVT; this experimental protocol has been reported pre-
viously [16]. Briefly, rats were ventilated for 60 min with
HVT 40 mL/kg to peak airway pressures of 35 cm H2O
and a respiratory rate of 40 breaths/min 100% oxygen.
When high-stretch ventilation was discontinued, the ani-
mals were allowed to recover, and subsequently returned to
their cages. Group III: HVT + low tidal volume (LVT); rats
received HVT as in Group II, plus an additional low tidal
volume of 6 mL/kg (LVT 6 h) to peak airway pressures of
approximately 8 cm H2O and 100% oxygen. Group IV:
HVT + ADSCs; rats received HVT as in Group II,
plus autologous ADSCs (5 × 106) were slowly infused
approximately 5 min via a jugular venous cannula after
1 h of HVT 40 mL/kg. After ADSCs were infused, the
animals were allowed to recover as in Group II.
Anesthesia was maintained with repeated pentobarbital
(500 μg/kg/h intravenous) and muscle relaxation was
achieved with cisatracurium besylate 0.5 mg/kg. All animals
were sacrificed 7 after the experiments lasted for 7 hours.
Bronchoalveolar lavage fluid (BALF) was collected and
lungs were obtained for analysis.
Obtaining and processing bronchoalveolar lavage fluid (BALF)
Each animal was sacrificed by eyeball removal and blood
letting. After exsanguination, the right main bronchus of
rats in each group (n = 6) was tied with string at the right
hilum. BALF was obtained from the left lung (n = 6) byusing a 20-gauge angiocatheter ligated into the trachea
and then flushing through it 3 mL of 0.9% NaCl three
times. BALF recovery was always greater than 90%
from each animal and was centrifuged at 1,200 g for
10 min at 4°C to remove cell debris. Total cell numbers
per milliliter in the BALF were counted, and differen-
tial cell counts were performed. The supernatant was
stored at −80°C for subsequent analysis. The concen-
trations of tumor necrosis factor (TNF)-α, interleukin
(IL)-1β, IL-6, IL-10, transforming growth factor (TGF)-β1
and keratinocyte growth factor (KGF) in BALF fluid were
determined using enzyme-linked immunosorbent assay
(ELISA, R&D Systems, USA) kits. Total protein content of
BAL supernatant was determined using a BCA protein
assay kit (Pierce, USA).
Lung wet/dry weight ratio
The right upper lobe of the same rats (n = 6) was ligated,
excised, and weighed in a tared container immediately
after exsanguination. The right upper lobe was then dried
in an oven at 80°C until a constant weight was obtained
and the wet-to-dry lung weight ratio was calculated.
Lung histology
The right lower lung lobes of the same rats (n = 6) were
resected and fixed in 4% paraformaldehyde (Sigma-Aldrich)
for 24 h embedded in paraffin and stained with hematoxylin
and eosin (H&E) staining kit (Beyotime Institute of
Biotechnology, China) for microscopic observation.
Two random tissue sections from four different lungs
in each group were examined by a blinded investigator.
Each subject was assessed according to a five-point
scale: 0 = no injury; 1 = slight injury (25%); 2 =moderate
injury (50%); 3 = severe injury (75%); and 4 = very severe
injury (almost 100%).
RNA extraction and real-time polymerase chain reaction
(PCR) for α,β, and γ-ENaC
Total RNA from the residual right frozen tissues of the
same rats (n = 6) was isolated using Trizol reagent.
Quantitative real-time polymerase chain reaction (qPCR)
was performed using SYBR Premix Ex Taq (Takara, Japan)
in a total volume of 20 μl on a 7300 Real-Time PCR System
(Takara, Japan): 95°C for 30 s, then 40 cycles of 95°C for







The comparative Ct method was used as described by
Livak [27] for quantitation of gene expression. The Ct
values of samples (group II–IV) and sham (group I)
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hydrogenase (GAPDH). The relative levels of gene ex-
pression were calculated as ΔCt1 = Ct of ENaC – Ct of
GAPDH (group II–IV) and ΔCt2 = Ct of ENaC – Ct of
GAPDH (group I), and the fold change of gene expression
was calculated by the 2-ΔΔCt method where ΔΔCt =ΔCt1–
ΔCt2. Experiments were repeated in triplicate.
Western blotting analysis
The right lung tissues proteins of other rats in each group
(n = 6) were obtained with 1 ml of lysis buffer and 1 ml of
extraction buffer using a protein extraction kit (Pierce)
according to the manufacturer’ s instructions and stored
at −80°C for analysis. Proteins were separated by 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and transferred onto polyvinylidene fluoride mem-
branes. After blocking with 5% nonfat dried milk in
Tris-buffered (Sigma-Aldrich) saline containing 0.05%
Tween 20 (Sigma-Aldrich), the membranes were incubated
with primary antibodies α, β, γ-ENaC (1: 300 Santa Cruz
Biotechnology, USA), and β-actin (1:500) overnight at 4°C,
and then reacted with horseradish peroxidase-conjugated
secondary antibody (1:5000) (Santa Cruz Biotechnology)
at room temperature for 1 h. Three 10-min TBS-Tween
washes were performed at 24°C after each incubation.
Using a western blot enhanced chemiluminescence method
[28], protein bands were visualized with a UVP Gel
imaging system (Upland, CA, USA) and analyzed with
Labworks software.
Na,K-ATPase function
The residual left lung basolateral membrane proteins
(BLMs) of the same rats (n = 6) were obtained from
basolateral cell membranes isolated from the 1–2 mm of
peripheral homogenizing lung tissue [29]. Na,K-ATPase
activity was quantified by comparing the amount of
inorganic phosphate (Pi) liberated from ATP over 1 h
by 20 μg of BLMs in the absence or presence of the
Na,K-ATPase inhibitor ouabain under conditions that
maximize Na,K-ATPase activity (Vmax), as described
previously [30]. Conditions used maximize Na,K-ATPase
activity (Vmax) to produce an index of functional,
membrane-bound receptor number.
AFC measurement
AFC from the alveolar airspace was performed by the
residual rats in each group as described previously [31].
Clearance was expressed by the change in concentration of
Evan’s blue-tagged albumin in an iso-osmolar alveolar
instillate placed into the alveolar airspace over a 30-minute
period of measurement (n = 6). AFC was calculated as fol-
lows: AFC = (1-C0/C30), where C0, is the protein concentra-
tion of the instillate before instillation, and C30 is the
protein concentration of the sample obtained at the end of30-min of mechanical ventilation. Clearance was expressed
as a percentage of total instilled volume cleared in 30 min.
Statistical analysis
All data were described as mean ± SEM. Statistical analysis
was performed using SPSS16.0 software. Results were com-
pared by one-way ANOVA followed by Student-Newman-
Keuls test, or by one-way ANOVA on ranks followed by
Bonferroni-Dunn test. Statistical significance was confirmed
at a two-tailed p value of <0.05.
Results
Morphology and characterization of ADSCs
ADSCs isolated from inguinal adipose had the ability to
self-renew and adhere to plastic, and expanded in culture
without losing differentiation potential. Flow cytometric
analysis demonstrated that ADSCs were positive for CD29,
CD90, and CD105, but negative for CD45 and CD14
(Figure 1A–E) as reported previously [32]. These cells
could be induced to differentiate into mature adipocytes,
which were confirmed by intracellular lipid droplets after
Oil Red-O staining (Figure 1G). ADSCs also differentiated
into osteoblasts and had the capacity to deposit calcium,
as demonstrated by alizarin red staining (Figure 1I). In the
control micrographs for adipogenesis and osteogenesis,
these changes were not observed (Figure 1F and 1H).
The above experimental results indicated that we have
successfully isolated mesenchymal stem cells from adi-
pose tissue.
ADSCs attenuated lung injury in HVT-induced acute
lung injury
Before sacrificed, all animals survived in each group.
H&E-stained lung sections showed normal lung tissue
structures in the sham group (Figure 2A). HVT induced
prominent lesions, such as interlobular septal thickening,
interstitial inflammation, hemorrhage, and infiltration of
neutrophils into alveolar spaces (Figure 2B). These were
rarely improved in the LVT group (Figure 2C). In con-
trast, the alveolar architecture was well preserved and
histological changes were attenuated in the ADSC-treated
group (Figure 2D). The computerized lung injury score
provided consistent results (p < 0.01 for sham vs. HVT and
HVT vs. HVT +ADSCs, Figure 2E). Lung edema assessed
by the wet/dry weight ratio method was significantly greater
in rats subjected to over-ventilation compared with
controls. However, treatment with ADSCs considerably
reduced edema (p < 0.01, Figure 2F).
Effect of ADSCs and LVT on total protein, neutrophil
infiltration, cytokines and chemokines in VILI
ADSCs significantly reduced VILI-induced increases in
TNF-α, IL-6, IL-1β, protein level, TGF-β1, total cell counts,
and neutrophil counts in BALF (p < 0.01, Figure 3A–F).
Figure 1 Surface markers and induced differentiation of ADSCs at passage 3. (A) CD29. (B) CD105. (C) CD90. (D) CD45. (E) CD14. (F) Oil
Red-O staining of control micrograph. (G) Oil Red-O staining after adipogenic induction. (H) Alizarin red staining of control micrograph.
(I) Alizarin red staining after osteogenic induction.
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and KGF (Figure 3H), epithelial-specific growth factor
and anti-inflammatory cytokines were remarkably in-
creased in the ADSC group. In contrast, although the
levels were ameliorated in LVT group, there was no
significant difference except in the case of neutrophil
counts (p < 0.05, Figure 3B).
Effects of ADSCs on gene and protein expression of
ENaC subunits
mRNA and protein expression levels of α-, β- and γ-ENaC
in rat lung were significantly lower in the HVT group,
compared with the sham group (p < 0.01) but the
mRNA and protein expression levels of the three ENaC
subunits were significantly increased following administra-
tion of ADSCs, compared with the HVT and LVT groups(p < 0.01, Figure 4A–E). α-ENaC mRNA levels were
significantly increased in the LVT group, compared with
the HVT group (p < 0.05, Figure 4A).
Effects of ADSCs on distal lung Na-K-ATPase pump activity
Na-K-ATPase pump activity in peripheral lung tissue was
examined 6 h after VILI and was decreased compared
with that in the control group. However, the activity was
significantly improved in the ADSCs group, to values very
close to those in controls (p < 0.01, Figure 4F).
Effects of ADSCs on alveolar fluid clearance
To examine the physiological significance of these changes
in mRNA and protein levels, we measured AFC rates in
our HVT model. Consistent with the results of other
studies, basal mean AFC was significantly decreased in
Figure 2 Effect of ADSCs on lung histopathology. (A) Sham group. (B) HVT group (C) HVT + LVT group. (D) HVT + ADSCs group. (E) Lung
injury score. (F) Lung wet/dry. Data are presented as mean ± SEM. ## p < 0.01 vs sham group. **p < 0.01 vs HVT group. n = 6 animals in each
group and each assay was repeated 3 times.
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fusion of ADSCs 6 h following the induction of ALI
significantly increased AFC rates (p < 0.01, Figure 4G).
Discussion
This study demonstrated that autologous transplantation
of ADSCs significantly ameliorated VILI through the
inhibition of several proinflammatory cytokines and by
increasing the lung’s ability to clear edema by up-
regulation of ENaC gene expression and Na,K-ATPase
activity in the lung.
VILI can cause capillary stress fracture of the
alveolocapillary barrier and the release of proinflammatory
mediators which not only increase lung permeability to
small and large solutes but also decrease active Na+
transport and AFC in association with down-regulation ofalveolar epithelial Na,K-ATPase functioning [16,33]. The
current study used a common rat model of VILI, with spe-
cific magnitude of overstretch (40 mL/kg) and 1-h duration
of injurious mechanical stimulation [16]. The rats subjected
to lung over-distension exhibited the expected pattern of
VILI namely lung inflammation, lung edema and consider-
able histopathological changes [34]. Moreover, in addition
to the decline in Na-K ATPase activity, ENaC gene and
protein expression levels were also significantly decreased
in rats subjected to HVT.
Treatment with ADSCs significantly reduced the de-
velopment of VILI in rats subjected to HVT. Our results
indicated that all the variables assessed in the animals
treated with ADSCs tended to recover towards the con-
trol values, i.e. edema and histological index of lung in-
jury, neutrophils counts and biomolecule concentrations
Figure 3 Effects of ADSCs on total protein, neutrophil infiltration, cytokines and chemokines response in BALF. (A) BALF total protein.
(B) neutrophil counts (C) TNF-α concentration (D) IL-6 concentration (E) TGF-β1 concentration (F) IL-β1 concentration (G) IL-10 concentration
(H) KGF concentration. Data are presented as mean ± SEM. ## p < 0.01 vs sham group. *p < 0.05 vs HVT group. **p < 0.01 vs HVT group. n = 6
animals in each group and each assay was repeated 3 times.
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dence for amelioration of the increased alveolocapillary
membrane permeability and the local inflammatory process
induced by HVT. The effectiveness of ADSCs in minimiz-
ing VILI was in agreement with the results of other studies,
where the protective effects of adult stem cells in VILI were
investigated using bone marrow-derived mesenchymal cells
[35,36]. Our results demonstrated that ADSCs also played a
therapeutic role in VILI by improving AFC through in-
creasing ENaC and Na,K-ATPase activity.
Investigators have reported that BALF in ALI contains
high levels of several pro-inflammatory cytokines, including
IL-1β, IL-6, IL-8, TNFα and TGFβ1 [37-39]. Several of
these cytokines have been shown to have opposing effects
on sodium transport and AFC. For example, TNFα de-
creased the expression of ENaC (α-, β-, γ-subunits) mRNAand protein levels [40]. Similarly, IL-1β [41] and TGFβ1
[42] decreased the expression of α-ENaC mRNA and
protein levels. However, these cytokines were significantly
reduced in the ADSC group in the present study. The
potential mechanism for the therapeutic effects may be
the immunomodulatory properties of MSCs which par-
ticipates in down-regulation of inflammatory reaction
[43]. Interestingly, the present study demonstrated notably
increased pulmonary expressions of anti-inflammatory
IL-10 in animals with ADSCs therapy. Another possible
mechanism of MSCs may be the production of several
epithelial-specific growth factors, specifically KGF. A
previous report demonstrated that MSCs restored AFC
via a KGF-dependent mechanism in an ex vivo perfused
human lung endotoxin-induced injury [44]. Alveolar
fluid transport in rat lung was partly improved by the
Figure 4 Effects of ADSCs on gene and protein expression of ENaC subunits. (A–C) α-, β- and γ-ENaC relative mRNA level. (D–E) α-, β- and
γ-ENaC protein expression. (F) Na,K-ATPase activity. (G) Alveolar Fluid Clearance. Data are presented as mean ± SEM. ## p < 0.01 vs sham group.
*p < 0.05 vs HVT group. **p < 0.01 vs HVT group. n = 6 animals in each group and each assay was repeated three times.
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pression [45] and Na,K ATPase activity [46]. The current
results also showed that ADSCs produced substantial
quantities of KGF in lung tissue. Therefore, we speculated
that ADSCs could be responsible for inhibiting cytokine
expression and reducing edema. However, further research
in this field should be made and focus on elucidating the
basic mechanisms responsible for the beneficial effects of
ADSC, as well as determining the practical issues involved
in producing a cell-based therapy for patients. In the
process, a novel therapy for ALI/ARDS might emerge.
The mortality of patients with ALI treated with the
LVT strategy was by reduced 9% compared with HVT-
treated patients [47]. Subsequently, several pathogenesis
studies have demonstrated that LVT reduces plasma levels
of surfactant protein D, a product of alveolar epithelial type
II cells and reduces the levels of inflammatory mediators in
the plasma (IL-6 and IL-8, and TNF receptors 1 and 2)
[22]. Although this lung-protective approach has proved to
be an effective barrier and anti-inflammatory strategy for
patients with ALI, LVT strategy had little therapeutic effect
compared with ADSCs treatment in the present study.However, it is possible that we analyzed our results at
an earlier time point.
Although the experimental design was similar to that
of conventional studies using rodent VILI models and
ADSC infusion, there were some limitations associated
with the current study, because not all the possible ranges
of variables were investigated. First, we did not provide
control for the effects of ADSCs on unventilated, LVT 7 h
alone and LVT treated at 0 time with ADSCs. However,
our found that LVT did not aggravate injury and ADSCs
can alleviate injury. Therefore, it would be expected that
these influence on these animals would be limited. Second,
although the proposed mechanism may serve as a scaffold
outlining the possible relationships among our study
parameters, the exact mechanisms underlying the observed
improvement in VILI through ADSCs administration are
likely to be more complex and possibly involve multiple
compensatory routes. Lastly, solid cause-and-effect re-
lationships underlying the exact mechanisms remain to be
elucidated. In conclusion, we have shown that autologous
transplantation of ADSCs has a better therapeutic effect
than LVT and can be used to alleviate lung injury and
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gene expression and Na,K-ATPase activity. The possible
mechanism responsible for this beneficial effect on AFC
is partly due to the secretion of paracrine soluble factors
such as KGF by the ADSCs and their anti-inflammatory
properties.
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